Neurocrine shows sustained pediatric results for CRENESSITY in two-year study
Go back to Neurocrine shows sustained pediatric results for CRENESSITY in two-year study| Neurocrine Biosciences, Inc. (NASDAQ: NBIX) | Delayed: 166.06 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $166.06 | 52 Week High | $58.46 | |||
| Open | $166.06 | 52 Week Low | $31.25 | |||
| Day High | $166.06 | P/E | N/A | |||
| Day Low | $166.06 | EPS | $-0.69 | |||
| Volume | 16 | |||||
